Brief: Opsens Announces 510(K) Submission To U.S. FDA For New Guidewire For The Tavr Procedure
13/12/2021 12:24
Dec 13 (Reuters) - Opsens Inc OPS.TO :
* OPSENS ANNOUNCES 510(K) SUBMISSION TO U.S. FDA FOR NEW
GUIDEWIRE
FOR THE TAVR PROCEDURE
Source text for Eikon: ID:nCNW3wl3na
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe